Overview
Current NAV
13.5900
As on 30-Dec-2025
Fund Size
481.041 Cr
Managed by Abhishek Bisen
Expense Ratio
0.74%
Latest reported
Exit Load Rules
2
Conditions apply
Scheme Snapshot
This growth scheme operates in the equity small cap category with a risk profile of Very High Risk. Inception date 11-Dec-2023. Use the navigation above to explore performance, risk, portfolio holdings, analysis & exit load structure.
Data shown is for informational purposes only and may be delayed.
Returns
Green = Positive, Red = Negative| Period | Absolute % | CAGR % | Category % | Index % |
|---|---|---|---|---|
| 1D | -0.68 | — | — | — |
| 1W | -1.89 | — | — | — |
| 1M | -3.55 | — | — | — |
| 3M | 0.61 | — | 1.47 | — |
| 6M | -0.86 | — | 0.20 | — |
| 1Y | -5.20 | — | -2.14 | — |
| 3Y | — | — | 22.11 | — |
| 5Y | — | — | 14.61 | — |
| 10Y | — | — | — | — |
Top Holdings
Portfolio Allocation (Top 8+)
Company
Nature
Sector
% of Corpus
Sun Pharmaceutical Industries Ltd.
EQ
Healthcare
14.44
Max Healthcare Institute Ltd.
EQ
Healthcare
7.84
JB Chemicals & Pharmaceuticals Ltd.
EQ
Healthcare
5.92
Divi's Laboratories Ltd.
EQ
Healthcare
5.38
Cipla Ltd.
EQ
Healthcare
4.77
Lupin Ltd.
EQ
Healthcare
4.10
Apollo Hospitals Enterprise Ltd.
EQ
Healthcare
4.03
Fortis Healthcare Ltd.
EQ
Healthcare
3.81
Acutaas Chemicals Ltd.
EQ
Healthcare
3.43
Jubilant Pharmova Ltd.
EQ
Healthcare
3.17
Aster DM Healthcare Ltd.
EQ
Healthcare
2.97
Krishna Institute of Medical Sciences Ltd
EQ
Healthcare
2.84
Analysis Highlights
PROS
Lower expense ratio: 0.74%
CONS
1Y annualised returns lower than category average by 3.06%
Exit Load
- 0.5% for redemption within 30 Days2024-12-30
- Exit load of 1%, if redeemed within 30 days.2023-11-20